Close
Nordic 9Nordic 9

ROI Verwaltungsgesellschaft (investor - Others)

Germany
See something wrong or missing? Let us know
Offices:Düsseldorf

ROI Verwaltungsgesellschaft mbH, founded in 1981, is the investment company of Roland Oetker, focusing on high tech companies within biotech and medtech.

Average round investment:3.29M USD
Average number per year:1.0
Distribution: 2026 (1)2022 (1)
Portfolio companies: Germany CancilicoGermany faCellitate
Mostly invests in: Germany Germany (2) Health services (1)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to ROI Verwaltungsgesellschaft

Name Criteria
United States AIX Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany BIF Partners
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Kerstin Bock
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Essential Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cancer Focus Fund
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Otto Braun
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Petra Wörwag
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Katharina Klohe
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Bulgaria Impetus Capital
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Cybernetix Ventures
83%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top